Business Development is a strategic function of TenNor, responsible for the portfolio strategy of the Company’s innovation pipeline as well as the planning, development and implementation of partnering strategy.

TenNor Therapeutics proactively embraces external partnering opportunities in Chinese and overseas markets. At present we are open for various cooperation modes such as out-licensing, co-development, CSO/distribution partnership, strategic alliances (including equity investment) through the clinical-stage products/projects on our innovation pipeline.

Via external partnering TenNor aim to accelerate the clinical development and commercialization of its innovative products so as to benefit patients in China and eventually worldwide as soon as possible. We warmly welcome any inquiries from domestic and overseas partners who are in great strategic/product synergies with us.